← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cubrc, Inc.
Buffalo, NY
$49,583,778
Total funding
18
Grants
Funding over time
peak $7.6M · FY2008–22$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$37,053,642 · 3
DOD$10,675,349 · 9
NASA$1,854,787 · 6
By mechanism
N01$33,851,868 · 1
—$12,530,136 · 15
R01$2,803,878 · 1
R21$397,896 · 1
Investigators at Cubrc, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
DEVELOPMENT OF NOVEL COUNTERMEASURES FOR RESPIRATORY DISEASES$5,768,972
N01 · FY2011 · AI
DEVELOPMENT OF NOVEL COUNTERMEASURES FOR RESPIRATORY DISEASES$5,582,446
N01 · FY2012 · AI
NOVEL VIRAL BIOWARFARE AGENT IDENTIFICATION AND TREATMENT (NOVBAIT) PHASE 5$3,682,105
· FY2010 · Department of the Army
DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASE$3,227,357
N01 · FY2013 · AI
DEVELOPMENT OF NOVEL COUNTERMEASURES FOR RESPIRATORY DISEASES$3,227,357
N01 · FY2013 · AI
DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASES$3,184,516
N01 · FY2016 · AI
DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASES$3,184,516
N01 · FY2016 · AI
DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASES$3,023,963
N01 · FY2014 · AI
DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASES$2,901,309
N01 · FY2014 · AI
NEW COOPERATIVE AGREEMENT FOR INFORMATION FUSION RESEARCH$1,970,699
· FY2009 · Department of Defense
MODULATION OF BURKHOLDERIA PSEUDOMALLEI IMMUNE RESPONSES BY HUMAN-LIKE T CELL EPITOPES$1,862,942
· FY2017 · Defense Threat Reduction Agency
DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASES$1,743,108
N01 · FY2015 · AI
DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASES$1,743,107
N01 · FY2015 · AI
DEFENSE AGAINST VIRAL ILLNESS PHASE I$1,356,980
· FY2009 · Department of the Army
STEP TWO PROPOSAL: EXPERIMENTAL TESTING TO REDUCE UNCERTAINTY IN ENTRY, DESCENT, AND LANDING (EDL) THERMAL PROTECTION SYSTEM (TPS) DESIGN HAS BEEN PR$1,049,693
· FY2014 · National Aeronautics and Space Administration
FY15 ANNUAL PROGRAM PLAN, CUBRC, INC.$866,350
· FY2015 · Department of the Army
Development of TP-217 as a highly efficacious, broad-spectrum antibiotic for the$828,940
R01 · FY2011 · AI
Development of TP-217 as a highly efficacious, broad-spectrum antibiotic for the$521,128
R01 · FY2012 · AI
Development of TP-217 as a highly efficacious, broad-spectrum antibiotic for the$496,101
R01 · FY2015 · AI
Development of TP-217 as a highly efficacious, broad-spectrum antibiotic for the$481,592
R01 · FY2014 · AI